企業プロフィール
Lipocine Inc. 株価・ニュース・カタリスト
- ティッカー:
- LPCN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
2.05 USD (-2.84%)
終値
最終更新: 2026年8月17日
18.5M USD
時価総額
株価変動の要因
As of Aug 17, 2026, LPCN closed down 2.84% at $2.05. No new same-company headline was identified in the current news window.
企業概要
Oral Drug-Delivery Platform
Lipocine develops oral formulations intended to improve the delivery of therapeutics that are otherwise difficult to administer effectively by mouth.
LPCN 1154
LPCN 1154 is an oral formulation of brexanolone developed for postpartum depression. A Phase 3 study did not meet its primary endpoint, leaving the program's future development path uncertain.
Product-Focused Development Model
The company applies its formulation technology to established active pharmaceutical ingredients, seeking differentiated dosing, convenience or pharmacokinetic profiles in endocrine and neuropsychiatric indications.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。